145 related articles for article (PubMed ID: 28194852)
1. Development of a transformation model to derive general population-based utility: Mapping the pruritus-visual analog scale (VAS) to the EQ-5D utility.
Park SY; Park EJ; Suh HS; Ha D; Lee EK
J Eval Clin Pract; 2017 Aug; 23(4):755-761. PubMed ID: 28194852
[TBL] [Abstract][Full Text] [Related]
2. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK
Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
[TBL] [Abstract][Full Text] [Related]
3. Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.
Wang L; Lu Y; Dai Z; Shi P; Xu J; Chang F; Lu Y
Health Qual Life Outcomes; 2022 Dec; 20(1):164. PubMed ID: 36522665
[TBL] [Abstract][Full Text] [Related]
4. EQ-5D Brazilian population norms.
Santos M; Monteiro AL; Santos B
Health Qual Life Outcomes; 2021 Jun; 19(1):162. PubMed ID: 34112207
[TBL] [Abstract][Full Text] [Related]
5. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
6. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
8. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
[TBL] [Abstract][Full Text] [Related]
9. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
10. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
Moore A; Young CA; Hughes DA
Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH
Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011
[TBL] [Abstract][Full Text] [Related]
12. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
Bae E; Choi SE; Lee H; Shin G; Kang D
BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
[TBL] [Abstract][Full Text] [Related]
13. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
[TBL] [Abstract][Full Text] [Related]
14. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
Monroy M; Ruiz MA; Rejas J; Soto J
Health Qual Life Outcomes; 2018 Sep; 16(1):177. PubMed ID: 30200982
[TBL] [Abstract][Full Text] [Related]
16. Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities.
Gu NY; Botteman MF; Ji X; Bell CF; Carter JA; van Hout B
Health Qual Life Outcomes; 2011 Dec; 9():119. PubMed ID: 22208861
[TBL] [Abstract][Full Text] [Related]
17. EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study.
König HH; Brettschneider C; Lühmann D; Kaduszkiewicz H; Oey A; Wiese B; Werle J; Weyerer S; Fuchs A; Pentzek M; Conrad I; Röhr S; Weeg D; Bickel H; Heser K; Wagner M; Scherer M; Maier W; Riedel-Heller SG; Hajek A
Qual Life Res; 2020 Dec; 29(12):3223-3232. PubMed ID: 32851600
[TBL] [Abstract][Full Text] [Related]
18. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea.
Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS
Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982
[TBL] [Abstract][Full Text] [Related]
19. Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents.
Åström M; Rolfson O; Burström K
Appl Health Econ Health Policy; 2022 May; 20(3):383-393. PubMed ID: 35083734
[TBL] [Abstract][Full Text] [Related]
20. Estimating EQ-5D utilities based on the Short-Form Long Term Conditions Questionnaire (LTCQ-8).
Tsiachristas A; Potter CM; Rocks S; Peters M; Cundell M; McShane R; Batchelder L; Fox D; Forder JE; Jones K; Waite F; Freeman D; Fitzpatrick R
Health Qual Life Outcomes; 2020 Aug; 18(1):279. PubMed ID: 32795317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
